Ligand validation:6ZT7

AHR: alpha-L-arabinofuranose

AHR is a Ligand Of Interest in 6ZT7 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZT7_AHR_C_516	28%	13%	0.207	0.86	1.65	2.33	2	5	0	0	100%	0.5
6ZT7_AHR_B_501	23%	19%	0.23	0.852	1.82	1.62	3	5	0	0	100%	0.5
6ZT7_AHR_A_518	17%	13%	0.249	0.824	1.69	2.26	2	5	0	0	100%	0.5
6ZT9_AHR_B_501	40%	7%	0.178	0.89	1.77	3	2	8	2	0	100%	1
5OCP_AHR_A_407	97%	41%	0.066	0.978	1.04	1.26	-	1	0	0	100%	0.5
3UG4_AHR_F_487	95%	35%	0.071	0.976	1.63	0.94	2	-	0	0	100%	1
2YDT_AHR_A_501	93%	41%	0.064	0.978	0.97	1.33	-	2	0	0	90%	0.9
2YDP_AHR_A_501	85%	49%	0.083	0.967	0.64	1.31	-	1	0	0	90%	0.9
1WD4_AHR_A_602	84%	43%	0.1	0.962	1.2	1.02	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.